Crossmark

An integrated genomic and metabolomic approach for defining survival time in adult oligodendrogliomas patients

Crossref DOI link: https://doi.org/10.1007/s11306-019-1522-5

Published Online: 2019-04-29

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bund, Caroline https://orcid.org/0000-0001-6916-858X
Guergova-Kuras, Mariana

Cicek, A. Ercument

Moussallieh, François-Marie

Dali-Youcef, Nassim

Piotto, Martial

Schneider, Pilar

Heller, Rémy

Entz-Werle, Natacha

Lhermitte, Benoît

Chenard, Marie-Pierre

Schott, Roland

Proust, François

Noël, Georges

Namer, Izzie Jacques
License Information

Text and Data Mining valid from 2019-04-29
More Information

Article History

Received: 15 October 2018

Accepted: 1 April 2019

First Online: 29 April 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: The Ethics Committee of Strasbourg approved the study (No. 100/2003, 09.12.2003 and No. 2013-37, 12.11.2013).

: A written informed consent was obtained from all the included patients.